Woodline Partners LP Trims Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Woodline Partners LP decreased its holdings in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 44.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 187,956 shares of the company's stock after selling 148,827 shares during the period. Woodline Partners LP owned about 0.22% of HealthEquity worth $18,034,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of HQY. Arcadia Investment Management Corp MI purchased a new position in shares of HealthEquity during the fourth quarter valued at $26,000. Transce3nd LLC acquired a new stake in HealthEquity in the fourth quarter worth about $29,000. Smartleaf Asset Management LLC lifted its holdings in shares of HealthEquity by 34.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock worth $37,000 after purchasing an additional 98 shares during the period. Proficio Capital Partners LLC purchased a new stake in HealthEquity in the fourth quarter valued at approximately $39,000. Finally, UMB Bank n.a. increased its holdings in HealthEquity by 65.6% in the 4th quarter. UMB Bank n.a. now owns 414 shares of the company's stock worth $40,000 after buying an additional 164 shares during the period. Hedge funds and other institutional investors own 99.55% of the company's stock.

HealthEquity Stock Performance

HQY opened at $98.79 on Thursday. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. The firm has a fifty day moving average price of $88.09 and a 200 day moving average price of $97.24. HealthEquity, Inc. has a 1 year low of $65.01 and a 1 year high of $115.59. The stock has a market cap of $8.54 billion, a P/E ratio of 90.63, a P/E/G ratio of 1.60 and a beta of 0.45.

Analyst Ratings Changes

Several brokerages have commented on HQY. Barrington Research restated an "outperform" rating and set a $112.00 price objective on shares of HealthEquity in a research note on Friday, April 11th. The Goldman Sachs Group dropped their price objective on shares of HealthEquity from $107.00 to $94.00 and set a "neutral" rating on the stock in a report on Thursday, March 27th. Raymond James raised shares of HealthEquity from an "outperform" rating to a "strong-buy" rating and dropped their price objective for the company from $120.00 to $115.00 in a report on Tuesday, March 25th. KeyCorp dropped their price objective on shares of HealthEquity from $110.00 to $100.00 and set an "overweight" rating on the stock in a report on Wednesday, April 16th. Finally, Wells Fargo & Company upped their price objective on shares of HealthEquity from $110.00 to $125.00 and gave the company an "overweight" rating in a report on Wednesday, February 26th. One equities research analyst has rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Buy" and an average price target of $111.75.

Insider Activity at HealthEquity

In related news, EVP Michael Henry Fiore sold 8,881 shares of the business's stock in a transaction on Friday, April 4th. The shares were sold at an average price of $78.26, for a total value of $695,027.06. Following the completion of the transaction, the executive vice president now directly owns 56,655 shares in the company, valued at $4,433,820.30. The trade was a 13.55% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Robert W. Selander sold 5,750 shares of the company's stock in a transaction on Wednesday, April 9th. The stock was sold at an average price of $77.65, for a total transaction of $446,487.50. Following the transaction, the director now owns 84,969 shares of the company's stock, valued at $6,597,842.85. This represents a 6.34% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 2.20% of the company's stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.